SS INNOVATIONS INTERNATIONAL, INC. Financing Cash Flow
SS INNOVATIONS INTERNATIONAL, INC. (SSII) reported Financing Cash Flow of $21.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- SS INNOVATIONS INTERNATIONAL, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.48M.
- SS INNOVATIONS INTERNATIONAL, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $18.16M, a 18.95% decline year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.37M, a 59.74% decline year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $3.09M, a 327.71% increase year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. net cash provided by (used in) financing activities for fiscal 2025 was $26.17M, a 177.60% increase from fiscal 2024.
- SS INNOVATIONS INTERNATIONAL, INC. net cash provided by (used in) financing activities for fiscal 2024 was $9.43M, a 58.65% decline from fiscal 2023.
- SS INNOVATIONS INTERNATIONAL, INC. net cash provided by (used in) financing activities for fiscal 2023 was $22.80M, a 286.63% increase from fiscal 2022.
- SS INNOVATIONS INTERNATIONAL, INC. net cash provided by (used in) financing activities for fiscal 2022 was $5.90M, a 934.51% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $21.64M 10-Q · filed 2026-08-13 | $23.01M derived: sum of 3 quarters · filed 2026-08-13 | $26.10M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $18.16M 10-Q · filed 2026-05-13 | $19.53M derived: sum of 2 quarters · filed 2026-05-13 | $22.62M derived: sum of 3 quarters · filed 2026-05-13 | $21.92M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.46M derived: sum of 2 quarters · filed 2026-03-10 | $3.76M derived: sum of 3 quarters · filed 2026-08-13 | $26.17M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.39M derived: sum of 2 quarters · filed 2026-08-13 | $24.79M 10-Q · filed 2025-10-28 | $28.20M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$702.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $21.70M 10-Q · filed 2026-08-13 | $25.11M derived: sum of 3 quarters · filed 2026-08-13 | $25.84M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $22.41M 10-Q · filed 2026-05-13 | $25.82M derived: sum of 2 quarters · filed 2026-05-13 | $26.54M derived: sum of 3 quarters · filed 2026-05-13 | $29.19M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.13M derived: sum of 2 quarters · filed 2026-03-10 | $6.79M derived: sum of 3 quarters · filed 2026-03-10 | $9.43M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $722.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $3.38M derived: sum of 2 quarters · filed 2025-10-28 | $6.01M 10-Q · filed 2025-10-28 | $6.02M 10-Q · filed 2024-11-14 | $6.17M derived: sum of 4 quarters · filed 2025-10-28 | |||
| 2024-06-30 | $2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $5.29M 10-Q · filed 2025-08-06 | $6.24M 10-Q · filed 2024-09-06 | $5.44M derived: sum of 3 quarters · filed 2025-08-06 | $22.33M derived: sum of 4 quarters · filed 2025-08-06 | |||
| 2024-03-31 | $2.64M 10-Q · filed 2025-05-14 | $2.74M 10-Q · filed 2024-05-15 | $2.79M derived: sum of 2 quarters · filed 2025-05-14 | $19.67M derived: sum of 3 quarters · filed 2025-05-14 | $22.82M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $150.56K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | $17.04M derived: sum of 2 quarters · filed 2025-04-15 | $20.18M derived: sum of 3 quarters · filed 2025-04-15 | $22.80M 10-K · filed 2025-04-15 | $16.73M 10-K · filed 2024-03-22 | |||
| 2023-09-30 | $16.89M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-04-01 | $20.03M derived: sum of 2 quarters · filed 2025-04-01 | $22.65M 10-Q/A · filed 2025-04-01 | $24.02M 10-Q · filed 2023-11-13 | $25.72M derived: sum of 4 quarters · filed 2025-04-01 | |||
| 2023-06-30 | $3.14M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-03-10 | $5.76M 10-Q/A · filed 2025-03-10 | $11.26M 10-Q · filed 2023-08-07 | $8.83M derived: sum of 3 quarters · filed 2025-03-10 | $10.85M derived: sum of 4 quarters · filed 2025-03-10 | |||
| 2023-03-31 | $2.62M 10-Q/A · filed 2025-02-19 | $1.43M 10-Q · filed 2023-05-15 | $5.69M derived: sum of 2 quarters · filed 2025-02-19 | $7.70M derived: sum of 3 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | $3.07M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-12-20 | $5.09M derived: sum of 2 quarters · filed 2025-01-14 | $5.90M 10-K/A · filed 2024-12-20 | $5.38M 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | $2.01M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-01-14 | $2.82M 10-Q/A · filed 2025-01-14 | $1.51M 10-Q · filed 2022-11-30 | |||||
| 2022-06-30 | $809.41K 10-Q/A · filed 2025-01-14 | $72.08K 10-Q · filed 2022-11-30 | ||||||
| 2021-12-31 | $289.20K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $302.10K derived: sum of 2 quarters · filed 2023-03-31 | $334.95K derived: sum of 3 quarters · filed 2023-03-31 | $569.95K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $12.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-30 | $45.75K derived: sum of 2 quarters · filed 2022-11-30 | $280.75K 10-Q · filed 2022-11-30 | $280.75K 10-Q · filed 2022-11-04 | $486.69K derived: sum of 4 quarters · filed 2022-11-30 | |||
| 2021-06-30 | $32.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-30 | $267.85K 10-Q · filed 2022-11-30 | $473.80K derived: sum of 3 quarters · filed 2022-11-30 | $482.50K derived: sum of 4 quarters · filed 2022-11-30 | ||||
| 2021-03-31 | $235.00K 10-Q · filed 2022-11-30 | $440.94K derived: sum of 2 quarters · filed 2022-11-30 | $449.64K derived: sum of 3 quarters · filed 2022-11-30 | $465.77K derived: sum of 4 quarters · filed 2022-11-30 | ||||
| 2020-12-31 | $205.94K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-04 | $214.65K derived: sum of 2 quarters · filed 2022-11-04 | $230.78K derived: sum of 3 quarters · filed 2022-11-04 | $266.77K 10-K · filed 2022-11-04 | ||||
| 2020-09-30 | $8.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $24.83K derived: sum of 2 quarters · filed 2022-11-04 | $60.83K 10-Q · filed 2022-11-04 | $154.31K derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2020-06-30 | $16.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-04 | $52.13K 10-Q · filed 2022-11-04 | $145.62K derived: sum of 3 quarters · filed 2022-11-04 | $295.62K derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2020-03-31 | $36.00K 10-Q · filed 2022-11-04 | $129.49K derived: sum of 2 quarters · filed 2022-11-04 | $279.49K derived: sum of 3 quarters · filed 2022-11-04 | $369.49K derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2019-12-31 | $93.48K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-06 | $243.49K derived: sum of 2 quarters · filed 2022-09-06 | $333.49K derived: sum of 3 quarters · filed 2022-09-06 | $466.99K 10-K · filed 2022-09-06 | ||||
| 2019-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $240.00K derived: sum of 2 quarters · filed 2022-07-18 | $373.50K 10-Q · filed 2019-11-13 | $403.50K derived: sum of 4 quarters · filed 2022-07-18 | ||||
| 2019-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-18 | $223.50K 10-Q · filed 2022-07-18 | $253.50K derived: sum of 3 quarters · filed 2022-07-18 | |||||
| 2019-03-31 | $133.50K 10-Q · filed 2022-06-30 | $163.50K derived: sum of 2 quarters · filed 2022-06-30 | ||||||
| 2018-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $50.00K 10-K · filed 2022-02-22 | ||||||
| 2018-09-30 | $20.00K 10-Q · filed 2019-11-13 | |||||||
| 2017-12-31 | $81.19K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16 | $542.26K derived: sum of 2 quarters · filed 2019-04-16 | $535.88K derived: sum of 3 quarters · filed 2019-04-16 | $655.38K 10-K · filed 2019-04-16 | ||||
| 2017-09-30 | $461.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $454.70K derived: sum of 2 quarters · filed 2018-11-13 | $574.20K 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | -$6.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $113.12K 10-Q · filed 2018-08-13 | ||||||
| 2017-03-31 | $119.50K 10-Q · filed 2018-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |